BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 46 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,752 | -99.6% | 2,669 | -98.9% | 0.00% | -100.0% |
| Q2 2023 | $1,611,440 | -4.8% | 241,958 | +199.1% | 0.01% | -28.6% |
| Q1 2022 | $1,692,000 | -54.6% | 80,900 | -68.3% | 0.01% | -65.0% |
| Q4 2019 | $3,726,000 | +152.1% | 255,000 | +21.4% | 0.02% | +122.2% |
| Q3 2019 | $1,478,000 | +912.3% | 210,000 | +1001.7% | 0.01% | +800.0% |
| Q3 2018 | $146,000 | -75.9% | 19,062 | -71.0% | 0.00% | -50.0% |
| Q2 2018 | $605,000 | -0.7% | 65,809 | +10.7% | 0.00% | -33.3% |
| Q1 2018 | $609,000 | – | 59,451 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LUMINUS MANAGEMENT LLC | 157,099 | $4,565,000 | 0.66% |
| ACT CAPITAL MANAGEMENT, LLC | 42,000 | $1,221,000 | 0.63% |
| Knoll Capital Management, LLC | 20,000 | $581,000 | 0.30% |
| Artemis Investment Management LLP | 1,193,290 | $34,664,000 | 0.30% |
| Ghisallo Capital Management LLC | 225,000 | $6,539,000 | 0.25% |
| Monashee Investment Management LLC | 60,000 | $1,744,000 | 0.21% |
| AlphaCentric Advisors LLC | 25,000 | $727,000 | 0.20% |
| CAAS CAPITAL MANAGEMENT LP | 232,285 | $6,750,000 | 0.11% |
| AllSquare Wealth Management LLC | 5,402 | $157,000 | 0.09% |
| CNA FINANCIAL CORP | 9,479 | $275,000 | 0.08% |